Pliant Therapeutics Inc.
PLRX | NASDAQ
$0.85
-$0.01 (-1.04%)
Nov 2, 2026, 12:05 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 248K | 1.58M | 3.55M | 5.03M | 9.77M | 9.69M | 9.72M | 9.85M | 6.65M | 7.57M | 10.04M | 13.24M | 15.05M |
Cost of Revenue | 264K | 711K | 447K | 447K | 447K | 622K | 1.14M | 1.14M | 1.14M | 1.62M | 2.17M | 3.22M | 3.22M | 2.11M | 1.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -264K | -711K | -447K | -447K | -447K | -622K | -1.14M | -1.14M | -1.14M | -1.37M | -585K | 327K | 1.81M | 7.65M | 8.63M | 9.72M | 9.85M | 6.65M | 7.57M | 10.04M | 13.24M | 15.05M |
Operating Income | -97.48M | -119.21M | -156.37M | -186.12M | -219.86M | -234.91M | -228.37M | -222.08M | -207.75M | -194.44M | -184.15M | -174.51M | -158.77M | -141.08M | -127.2M | -114.4M | -109.57M | -102.83M | -97.54M | -91.95M | -81.5M | -75.57M |
Interest Income | 6.48M | 9.58M | 11.42M | 13.87M | 16.22M | 18.77M | 21.09M | 22.91M | 24.3M | 25.1M | 24.08M | 20.49M | 15.6M | 9.42M | 4.67M | 2.08M | 516K | 320K | 272K | 290K | 349K | 387K |
Pretax Income | -92.29M | -113.22M | -149.34M | -175.5M | -206.96M | -219.52M | -210.3M | -201.68M | -185.41M | -170.74M | -161.34M | -155.29M | -144.42M | -132.77M | -123.32M | -112.79M | -109.22M | -102.51M | -97.26M | -91.76M | -81.25M | -75.42M |
Net Income | -92.29M | -113.22M | -149.34M | -175.5M | -206.96M | -219.52M | -210.3M | -201.68M | -185.41M | -170.74M | -161.34M | -155.29M | -144.42M | -132.77M | -123.32M | -112.79M | -109.22M | -102.51M | -97.26M | -91.76M | -81.25M | -75.42M |
Selling & General & Admin | 33.35M | 39.61M | 46.92M | 53.75M | 57.68M | 59.31M | 59.06M | 58.38M | 59.47M | 59.02M | 57.93M | 58.33M | 51.8M | 45.52M | 39.95M | 33.54M | 32.39M | 29.57M | 27.56M | 25.34M | 22.26M | 19.82M |
Research & Development | 63.57M | 79.04M | 109.16M | 132.37M | 162.18M | 174.98M | 168.18M | 162.57M | 147.15M | 134.05M | 125.63M | 116.51M | 108.78M | 103.21M | 95.88M | 90.57M | 87.02M | 79.9M | 77.55M | 76.65M | 72.48M | 70.8M |
Other Expenses | 300K | -147K | -147K | -447K | -447K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 55K | 55K |
Operating Expenses | 97.22M | 118.5M | 155.93M | 185.67M | 219.41M | 234.29M | 227.23M | 220.95M | 206.62M | 193.07M | 183.56M | 174.84M | 160.58M | 148.74M | 135.83M | 124.12M | 119.41M | 109.47M | 105.11M | 101.99M | 94.74M | 90.63M |
Interest Expense | 951K | 1.76M | 2.56M | 3.26M | 3.32M | 3.38M | 3.02M | 2.51M | 1.95M | 1.4M | 1.27M | 1.26M | 1.25M | 1.1M | 791K | 474K | 173K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 97.48M | 119.21M | 156.37M | 186.12M | 219.86M | 234.91M | 228.37M | 222.08M | 207.75M | 194.69M | 185.73M | 178.05M | 163.8M | 150.85M | 136.89M | 124.12M | 119.41M | 109.47M | 105.11M | 101.99M | 94.74M | 90.63M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 61.92M | 61.8M | 61.37M | 61.41M | 61.39M | 61.22M | 60.54M | 60.73M | 60.38M | 60.18M | 59.9M | 59.69M | 59.17M | 56.06M | 48.78M | 46.8M | 36.17M | 36.03M | 36.02M | 35.91M | 35.67M | 35.65M |
Shares Outstanding (Diluted) | 61.92M | 61.8M | 61.37M | 61.41M | 61.39M | 61.22M | 60.54M | 60.73M | 60.38M | 60.18M | 59.9M | 59.69M | 59.17M | 56.06M | 48.78M | 46.8M | 36.17M | 36.12M | 36.02M | 35.91M | 35.75M | 35.65M |
EPS (Basic) | -1.49 | -1.84 | -2.44 | -2.88 | -3.40 | -3.61 | -3.47 | -3.34 | -3.09 | -2.87 | -2.59 | -2.61 | -2.51 | -2.63 | -2.90 | -2.87 | -3.02 | -2.84 | -2.71 | -2.57 | -2.29 | -3.04 |
EPS (Diluted) | -1.49 | -1.84 | -2.44 | -2.88 | -3.40 | -3.61 | -3.47 | -3.34 | -3.09 | -2.87 | -2.59 | -2.61 | -2.51 | -2.63 | -2.90 | -2.87 | -3.02 | -2.84 | -2.71 | -2.57 | -2.29 | -3.04 |
EBITDA | -88.11M | -107.98M | -143.12M | -168.49M | -201.76M | -214.08M | -205.16M | -197.04M | -181.41M | -166.81M | -156.99M | -150.38M | -139.52M | -128.67M | -120.14M | -110.53M | -107.33M | -100.88M | -95.79M | -90.35M | -80.02M | -74.22M |
EBIT | -89.37M | -109.49M | -144.82M | -170.27M | -203.64M | -216.14M | -207.28M | -199.17M | -183.45M | -169.34M | -160.07M | -154.05M | -143.19M | -131.69M | -122.56M | -112.32M | -109.05M | -102.51M | -97.33M | -91.81M | -81.43M | -75.57M |
Depreciation & Amortization | 1.27M | 1.51M | 1.7M | 1.79M | 1.89M | 2.06M | 2.13M | 2.13M | 2.05M | 2.53M | 3.08M | 3.67M | 3.67M | 3.03M | 2.42M | 1.79M | 1.72M | 1.63M | 1.54M | 1.46M | 1.41M | 1.36M |
Add to Watchlist
Select watchlists to add or remove PLRX